News

Johnson & Johnson JNJ, on its second-quarter conference call, stated that it expects its oncology sales to reach $50 billion ...
PFE's oncology unit is in focus ahead of Q2 results, with key drugs facing both rising demand and market pressure.
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
Pfizer, Moderna and AstraZeneca are producing the leading COVID-19 vaccine candidates. How effective are they in helping end the pandemic? Hotspots ranked Start the day smarter ☀️ Funniest cap ...
Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the increasing importance of ...
As two of the world's largest and most prolific drugmakers, Pfizer (PFE-0.54%) and AstraZeneca (AZN-0.30%) both have grand visions for how to grow even larger over the coming years. And with ...
The British pharmaceutical company, AstraZeneca, which has a strong footprint in Delaware, has successfully fended off Pfizer’s takeover attempt. Pfizer officially announced it won’t pursue the deal ...
ABBV's oncology sales might have dipped in Q2 as gains from newer drugs face pressure from Imbruvica's ongoing decline.
LONDON— Pfizer Inc.PFE-1.21 % decrease; red down pointing triangle has agreed to buy part of AstraZeneca PLC’s AZN-0.40 % decrease; red down pointing triangle antibiotics business for up to $1 ...
Mixing doses of the Pfizer-BioNTech and AstraZeneca-Oxford vaccines generate a stronger immune response than having two rounds of the AstraZeneca shot, new U.K. research suggests, though the ...
Just one dose of the Pfizer or Oxford-AstraZeneca vaccines significantly reduces the risk of hospitalization for COVID patients in their 80s with preexisting health conditions, a preliminary study ...
Some got two doses of either Pfizer or AstraZeneca, both of which have been shown to be effective against Covid-19. Others got a dose of AstraZeneca, followed by one of Pfizer, or vice versa.